Chinook Therapeutics to Present at Upcoming Investor Conferences
March 02 2021 - 4:15PM
Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical
company focused on the discovery, development and commercialization
of precision medicines for kidney diseases, today announced that
Chinook management is scheduled to participate in fireside chats at
the following upcoming virtual investor conferences:
- H.C. Wainwright Global Life Sciences
Conference – fireside chat will be available on-demand
beginning Tuesday, March 9th at 7:00 am EST
- Oppenheimer 31st
Annual Healthcare Conference – Tuesday, March 16th
at 1:50 pm EST
To access the live webcasts and subsequent archived recordings
of these and other company presentations, please visit the
Investors section of Chinook’s website. The archived webcasts will
remain available for replay on Chinook’s website for 90 days.
About Chinook Therapeutics, Inc.Chinook
Therapeutics, Inc. is a clinical-stage biotechnology company
developing precision medicines for kidney diseases. Chinook’s
product candidates are being investigated in rare, severe chronic
kidney disorders with opportunities for well-defined clinical
pathways. Chinook’s lead program is atrasentan, an investigational
phase 3 endothelin receptor antagonist for the treatment of IgA
nephropathy and other primary glomerular diseases. BION-1301, an
investigational anti-APRIL monoclonal antibody, is being evaluated
in a phase 1b trial for IgA nephropathy. In addition, Chinook is
advancing CHK-336, an investigational oral small molecule LDHA
inhibitor for the treatment of primary hyperoxaluria, as well as
research programs for other rare, severe chronic kidney diseases,
including polycystic kidney disease. Chinook is building its
pipeline by leveraging insights in kidney single cell RNA
sequencing, human-derived organoids and new translational models,
to discover and develop therapeutics with differentiating
mechanisms of action against key kidney disease pathways. To learn
more, visit www.chinooktx.com.
Contact:Noopur LiffickVice President, Investor
Relations & Corporate Communicationsinvestors@chinooktx.com
media@chinooktx.com
Chinook Therapeutics (NASDAQ:KDNY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Chinook Therapeutics (NASDAQ:KDNY)
Historical Stock Chart
From Sep 2023 to Sep 2024